37.43
price down icon7.67%   -3.14
after-market 시간 외 거래: 37.71 0.28 +0.75%
loading
전일 마감가:
$40.57
열려 있는:
$40.75
하루 거래량:
1.05M
Relative Volume:
1.54
시가총액:
$1.39B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-38.99
EPS:
-0.96
순현금흐름:
$-20.74M
1주 성능:
-17.54%
1개월 성능:
-3.63%
6개월 성능:
+59.57%
1년 성능:
-24.58%
1일 변동 폭
Value
$37.39
$41.08
1주일 범위
Value
$37.39
$45.41
52주 변동 폭
Value
$20.85
$59.23

Harrow Inc Stock (HROW) Company Profile

Name
명칭
Harrow Inc
Name
전화
615.733.4731
Name
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
직원
382
Name
트위터
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
HROW's Discussions on Twitter

HROW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
37.44 1.50B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.09 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
439.99 20.14B 3.08B 1.24B 1.07B 25.61

Harrow Inc Stock (HROW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-11 개시 Cantor Fitzgerald Overweight
2025-06-12 개시 BTIG Research Buy
2025-06-10 개시 William Blair Outperform
2025-02-06 개시 H.C. Wainwright Buy
2024-12-04 재확인 B. Riley Securities Buy
2024-04-11 개시 Craig Hallum Buy
2022-09-08 재개 B. Riley Securities Buy
2021-10-14 재개 B. Riley Securities Buy
2021-09-24 개시 Aegis Capital Buy
2021-07-02 개시 Ladenburg Thalmann Buy
모두보기

Harrow Inc 주식(HROW)의 최신 뉴스

pulisher
02:12 AM

Is it too late to sell Harrow Inc.Earnings Growth Report & Real-Time Chart Breakout Alerts - newser.com

02:12 AM
pulisher
02:03 AM

What data driven models say about Harrow Inc.’s futurePortfolio Risk Report & Weekly High Conviction Trade Ideas - newser.com

02:03 AM
pulisher
11:00 AM

What institutional flow reveals about Harrow Inc.Dollar Strength & Entry and Exit Point Strategies - newser.com

11:00 AM
pulisher
06:34 AM

Using data tools to time your Harrow Inc. exitJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com

06:34 AM
pulisher
Oct 09, 2025

Weiss Ratings Reaffirms Sell (E+) Rating for Harrow (NASDAQ:HROW) - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Harrow, Inc. (HROW): A Bull Case Theory - Insider Monkey

Oct 08, 2025
pulisher
Oct 07, 2025

Will Harrow's (HROW) Affordability Push and New Leadership Shift its Long-Term Growth Trajectory? - simplywall.st

Oct 07, 2025
pulisher
Oct 07, 2025

Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Yahoo Finance

Oct 07, 2025
pulisher
Oct 06, 2025

ImprimisRx Announces Leadership Changes - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Is Harrow Inc. stock dividend yield sustainableWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Harrow names Frank Mullery as CEO of ImprimisRx subsidiary - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Harrow Health (HROW) Appoints New Leadership at ImprimisRx - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Harrow Health Announces New Leadership at ImprimisRx - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Harrow names Frank Mullery as CEO of ImprimisRx subsidiary By Investing.com - Investing.com Canada

Oct 06, 2025
pulisher
Oct 06, 2025

ImprimisRx announces leadership changes - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Leadership Appointments at ImprimisRx: Frank Mullery Named CEO and Bridseida Cruz as Head of Quality - Quiver Quantitative

Oct 06, 2025
pulisher
Oct 06, 2025

Frank Mullery named CEO; Bridseida Cruz named Head of Quality at ImprimisRx, Harrow subsidiary - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Intraday pattern recognizer results for Harrow Inc.Bull Run & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How to escape a deep drawdown in Harrow Inc.July 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Assessing Harrow’s Value After a 22.8% Surge and Recent Earnings Release - simplywall.st

Oct 05, 2025
pulisher
Oct 05, 2025

How to track smart money flows in Harrow Inc.Market Volume Report & Smart Money Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Harrow (NASDAQ:HROW) Trading Down 4.9%Should You Sell? - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

A Fresh Look at Harrow (HROW) Valuation Following Recent Share Price Momentum - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Harrow, Inc. (NASDAQ:HROW) Looks Just Right With A 27% Price Jump - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Research Analysts Issue Forecasts for Harrow Q3 Earnings - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

How to use Fibonacci retracement on Harrow Inc.2025 Top Gainers & High Yield Stock Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

B. Riley Comments on Harrow's Q4 Earnings (NASDAQ:HROW) - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN

Oct 02, 2025
pulisher
Oct 01, 2025

B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation - Nasdaq

Oct 01, 2025
pulisher
Oct 01, 2025

HROW: B. Riley Securities Increases Price Target to $74, Reitera - GuruFocus

Oct 01, 2025
pulisher
Oct 01, 2025

Harrow to purchase Melt Pharmaceuticals - Eyes On Eyecare

Oct 01, 2025
pulisher
Oct 01, 2025

B. Riley Adjusts Price Target on Harrow to $74 From $70, Maintains Buy Rating - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

William Blair Issues Positive Outlook for Harrow Earnings - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

What is William Blair's Estimate for Harrow FY2025 Earnings? - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Lake Street Maintains Harrow (HROW) Buy Recommendation - Nasdaq

Sep 29, 2025
pulisher
Sep 29, 2025

Harrow (NASDAQ:HROW) Shares Gap UpStill a Buy? - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

HROW Analyst Update: Lake Street Raises Price Target to $70 | HR - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

H.C. Wainwright reiterates Buy rating on Harrow Health stock, maintains $64 target - Investing.com Australia

Sep 29, 2025
pulisher
Sep 29, 2025

HC Wainwright Reaffirms Buy Rating for Harrow (NASDAQ:HROW) - MarketBeat

Sep 29, 2025

Harrow Inc (HROW) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Harrow Inc 주식 (HROW) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Opaleye Management Inc.
10% Owner
Jun 10 '25
Sale
30.80
15,000
462,033
90,000
Opaleye Management Inc.
10% Owner
Jun 09 '25
Sale
30.37
15,204
461,794
105,000
Opaleye Management Inc.
10% Owner
Jun 03 '25
Sale
30.04
3,000
90,116
122,000
Opaleye Management Inc.
10% Owner
Jun 04 '25
Sale
30.02
1,796
53,907
120,204
Opaleye Management Inc.
10% Owner
May 12 '25
Sale
25.90
10,000
258,959
130,000
Opaleye Management Inc.
10% Owner
May 13 '25
Sale
26.59
5,000
132,945
125,000
BOLL ANDREW R.
Chief Financial Officer
Apr 03 '25
Option Exercise
0.00
346,500
0
914,589
SAHAREK JOHN P.
CEO & President, ImprimisRx
Apr 03 '25
Option Exercise
0.00
277,200
0
576,863
BAUM MARK L
Chief Executive Officer
Apr 03 '25
Option Exercise
0.00
762,300
0
2,899,825
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
30.01
5,000
150,055
140,000
$19.77
price down icon 1.54%
$9.735
price down icon 2.50%
$53.95
price down icon 7.18%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.16%
$136.70
price down icon 1.40%
$439.99
price down icon 1.35%
자본화:     |  볼륨(24시간):